The tech behind the first FDA-approved CAR-T cell therapy
To develop the first-FDA approved CAR-T immunotherapy, Novartis used Thermo Fisher’s proprietary cell therapy systems (CTS) Dynabeads technology.
Archives for October 3, 2017
News In Brief
Juno opens HQ & cancer research site
Juno Therapeutics has opened its new headquarters and research facility in South Lake Union, Seattle, US.
Lonza to buy Shire's Cali mammalian manufacturing plant
Lonza will buy Shire’s manufacturing facility in Hayward, California to cater for demand for mammalian cell culture-based drug production.
Exclusive interview from Biotech Week Boston
Balancing the up and downstream: Repligen CEO talks R&D and M&A
Repligen’s customer GE Healthcare opted to make its latest Protein A ligand in-house, but CEO Tony Hunt remains confident in his firm’s long-term partnerships and diversified bioprocessing offering.
Six year wait for Humira biosimilar a win-win for Amgen and AbbVie, says lawyer
AbbVie’s settlement over the exclusivity of Humira creates a level of certainty for Amgen’s adalimumab biosimilars, according to a biotech lawyer.